Cadrenal Therapeutics Inc... (CVKD)
undefined
undefined%
At close: undefined
11.25
0.45%
After-hours Dec 13, 2024, 04:23 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22
Net Income -8.36M -6.71M
Depreciation & Amortization 1.98K 1.27K
Stock-Based Compensation 710.38K -
Other Working Capital 381.89K 202.84K
Other Non-Cash Items 3.97M 4.50M
Deferred Income Tax - -
Change in Working Capital 144.31K 607.74K
Operating Cash Flow -3.53M -1.20M
Capital Expenditures -3.25K -
Acquisitions - -
Purchase of Investments - -2.28K
Sales Maturities Of Investments - -
Other Investing Acitivies - -
Investing Cash Flow -3.25K -2.28K
Debt Repayment -250.00K -
Common Stock Repurchased - -
Dividend Paid - -
Other Financial Acitivies 250.00K -
Financial Cash Flow 11.90M 1.24M
Net Cash Flow 8.37M 32.59K
Free Cash Flow -3.53M -1.20M